Aalborg University Hospital is the largest hospital in the North Denmark Region, Denmark. It is also northern Jutland's largest employer, with approximately 6,500 employees. The hospital consists of Section South and North in Aalborg and Dronninglund Hospital.

During the past decade, Department of Oncology, Aalborg University Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Oncology, Aalborg University Hospital" #1 collaborator was "Aalborg University Hospital" with 1 trials as a collaborator, "Aarhus University Hospital" with 1 trials as a collaborator, "Copenhagen University Hospital at Herlev" with 1 trials as a collaborator, "Dako" with 1 trials as a collaborator and "Fonden Til Fremme af Klinisk- Eksperimentel Cancerforskning" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Department of Oncology, Aalborg University Hospital" are "Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials), "Colorectal Cancer Metastatic" (1 trials), "Metastatic Colorectal Cancer" (1 trials) and "Non-small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Department of Oncology, Aalborg University Hospital" in a lesser frequency.

Most popular intervention types in "Department of Oncology, Aalborg University Hospital" are "Drug" (5 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "60 Gy/30F" (1 trials), "66 Gy/33F" (1 trials), "Based on sensitivity analysis" (1 trials), "Cetuximab (Erbitux)" (1 trials) and "Epirubicin, cyclophosphamide and docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Oncology, Aalborg University Hospital" are 4 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Department of Oncology, Aalborg University Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Department of Oncology, Aalborg University Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Oncology, Aalborg University Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".